|Bid||0.00 x 800|
|Ask||0.00 x 2900|
|Day's Range||6.28 - 6.73|
|52 Week Range||2.87 - 8.58|
|Beta (5Y Monthly)||1.00|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 02, 2023 - Mar 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||7.56|
The chief executive of bluebird bio's oncology-focused spinout believes that this year, it will take off as a company in its own right.
Every investor in bluebird bio, Inc. ( NASDAQ:BLUE ) should be aware of the most powerful shareholder groups. And the...
bluebird bio, Pros Holdings and Norwegian Cruise Line are part of the Zacks Screen of the Week article.